4-(5-ISOPROPOXY-2-METHYL-4-NITROPHENYL)PYRIDINE, 95.0%, 25g

2-(4-Bromophenyl)thioacetamide, 95.0%, 250mg

4-Bromo-2,6-difluorobenzoic Acid>98.0%(GC)(T)5g

1,1,1-Trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-2,6-di-2-naphthalenyl-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide, 98%, 1g

4-Bromo-7-fluoro-1H-pyrrolo[3,2-c]pyridine, 97%, 500mg

6-Bromo-1H-indol-3-amine, 97%, 1g

Modular grid stand system Rectangular diagonal, Rectangular diagonal for 0.35 x 0.7 m rectangle, 78.5 mm, 1 Piece

Large incubators Heratherm Advanced Protocol, 381 l, IMH400-S, 1 Piece

8-Bromo-6-fluoroquinolin-3-ol, 95%, 50mg

1-(4-Bromo-phenyl)-5-methyl-1H-pyrazole-4-carboxylic acid, = 98.5% (HPLC), 1g

(2R,4R)-Ethyl 1-(2-amino-5-(3-nitroguanidino)pentanoyl)-4-methylpiperidine-2-carboxylate hydrochloride, 95%, 100g

tert-Butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate, 95%, 1g

1H-Thieno[2,3-d]imidazol-2(3H)-one, 95.0%, 5g